We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+11.75%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$65.7B
AUM Growth
+$6.62B
Cap. Flow
+$648M
Cap. Flow %
0.99%
Top 10 Hldgs %
27.2%
Holding
2,939
New
828
Increased
695
Reduced
744
Closed
553

Top Sells

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$400M
2
STZ icon
Constellation Brands
STZ
+$345M
3
META icon
Meta Platforms (Facebook)
META
+$286M
4
KVUE icon
Kenvue
KVUE
+$277M
5
ABBV icon
AbbVie
ABBV
+$258M

Sector Composition

Rank Sector Weight
1 Technology 16.4%
2 Healthcare 13.22%
3 Consumer Discretionary 12.71%
4 Financials 7.66%
5 Communication Services 7.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMP icon
76
Ameriprise Financial
AMP
$46.8B
$157M 0.24%
357,860
-91,633
-20% -$36.7M
RL icon
77
Ralph Lauren
RL
$22.2B
$154M 0.24%
822,521
-131,814
-14% -$21.8M
RSP icon
78
CALL
Invesco S&P 500 Equal Weight ETF
RSP
$96.1B
$154M 0.23%
+924,800
New +$149M
GLD icon
79
PUT
SPDR Gold Trust
GLD
$131B
$154M 0.23%
706,900
-703,500
-50% -$135M
VLO icon
80
Valero Energy
VLO
$89.8B
$153M 0.23%
895,359
+444,481
+99% +$63.7M
CC icon
81
Chemours
CC
$2.59B
$149M 0.23%
5,662,158
+1,750,148
+45% +$49.9M
WST icon
82
West Pharmaceutical
WST
$23.1B
$149M 0.23%
375,678
+312,531
+495% +$116M
TECH icon
83
Bio-Techne
TECH
$11.2B
$147M 0.22%
2,092,071
-199,865
-9% -$14.3M
SWTX
84
DELISTED
SpringWorks Therapeutics
SWTX
$146M 0.22%
2,966,622
-58,237
-2% -$2.69M
TME icon
85
Tencent Music
TME
$14.5B
$144M 0.22%
12,833,647
+2,382,197
+23% +$23.4M
FTNT icon
86
Fortinet
FTNT
$112B
$143M 0.22%
2,090,336
+959,254
+85% +$63.9M
HAS icon
87
Hasbro
HAS
$12.6B
$142M 0.22%
2,504,931
-754,056
-23% -$38.4M
IWM icon
88
PUT
iShares Russell 2000 ETF
IWM
$80.9B
$139M 0.21%
672,000
+5,400
+0.8% +$1.08M
AMGN icon
89
Amgen
AMGN
$203B
$137M 0.21%
483,440
+346,399
+253% +$101M
SNOW icon
90
Snowflake
SNOW
$92.9B
$136M 0.21%
838,508
+96,384
+13% +$18.7M
SPY icon
91
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$135M 0.21%
258,200
-10,300
-4% -$5.13M
KMB icon
92
Kimberly-Clark
KMB
$36.4B
$135M 0.21%
1,041,308
+612,021
+143% +$75.1M
CVS icon
93
CVS Health
CVS
$137B
$134M 0.2%
1,677,908
-3,168,513
-65% -$242M
VAL icon
94
Valaris
VAL
$5.51B
$134M 0.2%
1,777,516
-21,855
-1% -$1.47M
SE icon
95
Sea Limited
SE
$61.2B
$130M 0.2%
2,418,573
-2,110,447
-47% -$97.1M
DECK icon
96
Deckers Outdoor
DECK
$13.3B
$129M 0.2%
825,462
-1,603,008
-66% -$222M
SPGI icon
97
S&P Global
SPGI
$126B
$128M 0.2%
302,007
+182,909
+154% +$79.3M
AMAT icon
98
Applied Materials
AMAT
$426B
$127M 0.19%
618,179
+421,969
+215% +$77.4M
SMH icon
99
PUT
VanEck Semiconductor ETF
SMH
$67.6B
$126M 0.19%
+556,500
New +$112M
NVDA icon
100
CALL
NVIDIA
NVDA
$5.01T
$125M 0.19%
1,367,000
+373,000
+38% +$27M

Similar funds

Marshall Wace's Q1 2024 Portfolio in Review

As of Q1 2024, Marshall Wace held 2,939 positions worth $65.7B, up 11% from $59B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Marshall Wace's Q1 2024 filing shows 828 new, 695 increased, 744 reduced and 553 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 900,000 shares worth $433M. The largest sale was Walmart Inc, an estimated $400M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Marshall Wace's largest Q1 2024 buy was Vanguard S&P 500 ETF: 900,000 shares worth $433M.
  • Marshall Wace added most to Goldman Sachs in Q1 2024, an estimated $374M increase.
  • Marshall Wace's biggest Q1 2024 reduction was Walmart Inc, cutting an estimated $400M.
  • Marshall Wace fully exited Celsius Holdings in Q1 2024, selling an estimated $143M.
  • Marshall Wace's ten largest holdings make up 27% of its $65.7B portfolio in Q1 2024.
  • Marshall Wace opened 828 new positions and closed 553 in Q1 2024.
  • Marshall Wace's portfolio value rose 11% quarter-over-quarter to $65.7B.

Based on Marshall Wace's 13F filing for Q1 2024, filed 15 May 2024.